Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Meningeal Carcinomatosis × camrelizumab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 9 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Uterine Cervical Neoplasms 2 Nasopharyngeal Carcinoma 2 Liver Neoplasms 2 Esophageal Neoplasms 2 Cervical Cancer Metastatic 2 Carcinoma, Non-Small-Cell Lung 2 Adenocarcinoma 2 Triple Negative Breast Neoplasms 1 Salivary Gland Neoplasms 1 Recurrence 1 Pancreatic Neoplasms 1 Non-squamous Non-small-cell Lung Cancer 1 Mouth Neoplasms 1 Lung Neoplasms 1 Locally Advanced Rectal Cancer 1 Leukemia, Myeloid, Acute 1 Laryngeal Neoplasms 1 Gestational Trophoblastic Disease 1 Gallbladder Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Squamour Cell Cancer 1 Endometrioid Endometrial Cancer 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1 Advanced Gastric Cancer 1

Interventions

Pemetrexed 9 Spinal Puncture 5 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 Trastuzumab 3 Radiotherapy 3 trastuzumab deruxtecan 2 pembrolizumab 2 osimertinib 2 aflutinib 2 Radiotherapy, Intensity-Modulated 2 tucatinib 1 toripalimab 1 sacituzumab govitecan 1 pertuzumab 1 peginterferon alfa-2b 1 lenvatinib 1 azeliragon 1 avelumab 1 adavosertib 1 WP 744 1 Vitamin B 12 1 Temozolomide 1 Referral and Consultation 1 Radiosurgery 1 Radiation 1 Probability 1 Physical Examination 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡